Skip to main navigation Skip to search Skip to main content

Phase II study of pembrolizumab checkpoint blockade following chemoimmunotherapy for primary central nervous system lymphoma: BLOCK CNS Lymphoma

Project: Research

Project Details

Short titlePrimary central nervous system lymphoma
AcronymPCNSL
StatusActive
Effective start/end date22/11/21 → 31/12/26

Keywords

  • pembrolizumab
  • chemoimmunotherapy
  • lymphoma
  • central nervous system

Clinical Trial Phase

  • Phase II
  • Sponsor is Monash University

Access Project